Clinical Trial Update: EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS

View source ↗

Summary

A completed Bayer-sponsored trial assesses the efficacy and long-term safety of KOGENATE for Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• KOGENATE Bayer/FS (recombinant coagulation factor VIII)

Snippet

Sponsor: Bayer | Conditions: Hemophilia A | Status: COMPLETED